Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Canada
42 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationOE MRI to Predict Treatment Response After TACE in HCC Patients
- Where
- Montreal
- Age
- 18 years to 70 years
- People
- 60
- Run by
- Université de Montréal
See details and how to joinNCT07617038 - No phaseTaking peopleEarly Detection of Liver Cancer by QUS
- Where
- Montreal
- Age
- 18 years and over
- People
- 328
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT06345508 - No phaseTaking peopleMR Guidance for Liver and Pancreas
- Where
- Toronto
- Age
- 18 years and over
- People
- 30
- Run by
- University Health Network, Toronto
See details and how to joinNCT03582189 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Toronto
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleSpinal Anesthesia For Enhanced Recovery After Liver Surgery
- Where
- Winnipeg
- Age
- 18 years and over
- People
- 128
- Run by
- University of Manitoba
See details and how to joinNCT03715517 - Phase 4WithdrawnEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Burlington
- Age
- 18 years to 64 years
- People
- 2,076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - Phase 2Taking peopleCabozantinib to Treat Recurrent Liver Cancer Post Transplant
- Where
- Toronto
- Age
- 18 years and over
- People
- 20
- Run by
- University Health Network, Toronto
See details and how to joinNCT04204850 - No phaseTaking people(3D) Ultrasound Imaging Liver and Kidney
- Where
- London
- Age
- 18 years and over
- People
- 40
- Run by
- Western University, Canada
See details and how to joinNCT03844399 - Phase 1/2Taking peopleA Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
- Where
- Toronto
- Age
- 18 years and over
- People
- 178 worldwide
- Run by
- Iterion Therapeutics
See details and how to joinNCT05797805 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Toronto
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseNot yet taking people in CanadaThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Calgary, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Saskatoon, Sherbrooke, Toronto, Vancouver
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - Phase 3Taking peopleTransarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma
- Where
- London
- Age
- 18 years and over
- People
- 128
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT03895359 - No phaseTaking peopleStandard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer
- Where
- London
- Age
- 18 years and over
- People
- 110
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT04745390 - Phase 1/2Taking peopleUsing Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
- Where
- London, Toronto
- Age
- 18 years to 70 years
- People
- 48
- Run by
- University Health Network, Toronto
See details and how to joinNCT06725121 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- Hamilton, Montreal, Ottawa, Toronto, Vancouver
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735 - Phase 2Taking peopleDurvalumab and Tremelimumab in Resectable HCC
- Where
- Toronto
- Age
- 18 years and over
- People
- 28 worldwide
- Run by
- University Health Network, Toronto
See details and how to joinNCT05440864 · EU 2023-508863-59-01 - Phase 2Not yet taking people in CanadaGemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA
- Where
- Toronto
- Age
- 18 years and over
- People
- 40
- Run by
- University Health Network, Toronto
See details and how to joinNCT06569225